Get startedLog in
    Picture of Dingdang Health Technology logo

    9886 — Dingdang Health Technology Income Statement

    0.000.00%
    hk flag iconLast trade - 00:00
    Consumer DefensivesHighly SpeculativeSmall CapValue Trap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Dingdang Health Technology, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

    2019
    December 31st
    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:PROSPECTUSPROSPECTUSPROSPECTUSARSARS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue1,2762,2293,6794,3294,857
    Cost of Revenue
    Gross Profit4707661,1621,4501,511
    Selling / General / Administrative Expenses
    Research And Development
    Unusual Expense / Income
    Other Operating Expenses
    Total Operating Expenses1,5363,1205,2437,1535,068
    Operating Profit-260-892-1,564-2,824-211
    Total Net Non Operating Interest Income / Expense
    Net Income Before Taxes-266-901-1,582-2,832-221
    Provision for Income Taxes
    Net Income After Taxes-274-920-1,599-2,842-231
    Minority Interest
    Net Income Before Extraordinary Items
    Net Income-277-924-1,578-2,833-226
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income-277-924-1,578-2,833-226
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS-0.206-0.688-1.16-3.33-0.168